Who Owns a Custom Formula? Understanding Product IP
Share
At Australian Private Label, formula IP ownership is included as standard in our full custom-formulation packages. You are commissioning a formula developed for your brand, not simply licensing an existing APL stock formula. The precise scope of the ownership transfer, the documents supplied and the point at which transfer occurs are confirmed in your project agreement.
This is an important difference between full custom development and private label. “Who owns the formula?” should never be left to assumption: it should be answered clearly before development begins.
What does formula IP ownership mean?
A product formula can be valuable confidential business information. In practical terms, formula ownership means the rights to the custom formula are assigned as set out in the project agreement, allowing your business to control that formula rather than relying on an open-ended licence from the developer.
Formula ownership is a contractual issue, so the written agreement matters. IP Australia recommends that collaborators define existing IP, newly created IP, ownership, access, confidentiality and commercial use in their agreements. Its guidance also explains that recipes and formulas may be protected as trade secrets when they remain confidential. You can read more in IP Australia’s overview of IP rights and its IP management guidance for collaborations.
How APL’s development pathways differ
Full custom formulation
APL develops a new formula against an approved product brief. Formula IP ownership is included in the custom-formulation package as standard. Your proposal and project agreement identify the deliverables and the terms of transfer.
Private label or white label
You select an established formula and sell the finished product under your brand. The underlying stock formula is not normally transferred to each brand using it. Your business owns its own brand assets, but it does not automatically own APL’s pre-existing base formula.
Semi-custom development
An existing base may be adjusted for a particular brief. Because a semi-custom product can combine pre-existing know-how with newly developed elements, the ownership and permitted use need to be stated in the written scope. Do not assume a colour, fragrance or active adjustment converts a stock base into fully assigned formula IP.
What is included in APL’s custom-formulation package?
A custom project is more than a formula on paper. The package is designed to take a commercially considered concept through development and toward production. Depending on the approved scope, the work includes:
- project briefing and technical scoping;
- development samples for review;
- senior chemist review and an optional in-lab consultation;
- formula IP ownership transfer;
- stability assessment and agreed testing requirements;
- regulatory-aligned labelling and claims guidance; and
- a costing and commercialisation discussion with a bulk manufacturing quotation.
The final proposal remains the source of truth for your project because product category, testing, claims, packaging and market requirements vary.
What does formula ownership not automatically include?
Owning a custom formula does not mean every asset connected with the product transfers automatically. Your agreement should distinguish the formula from:
- your brand name, trademark and domain;
- packaging artwork, photography and copy created by separate suppliers;
- third-party ingredient technology, supplier trademarks or proprietary raw-material information;
- APL’s general manufacturing methods, quality systems and facility know-how;
- regulatory registrations, listings or approvals; and
- claims evidence, test reports and certificates that are outside the agreed development scope.
If you expect a particular technical file, manufacturing transfer pack, test report or source document, put it in the scope before signing.
How the product brief protects the project
Clear ownership starts with a clear definition of what is being developed. APL’s product development brief records the company and product, project summary, distribution channel, target markets, benchmarks, product characteristics, claims, fragrance, pack size, shelf life, testing, packaging, production volume, target finished-unit cost and launch date.
This creates a shared reference point for the formula. It helps separate the agreed custom product from later additions, packaging changes or new claims that may require further development.
Questions to confirm before development begins
- Is this project full custom, semi-custom or private label?
- Which formula rights are included, and when does the transfer take effect?
- Which documents, specifications and test reports will be supplied?
- What information must remain confidential, and who may access it?
- Are any third-party ingredients, technologies or licences involved?
- What happens if the brief changes after development starts?
- What would be required if the brand later chooses a different manufacturing arrangement?
Frequently asked questions
Does APL own my custom formula?
For APL’s full custom-formulation packages, formula IP ownership is included for the client as standard. The project agreement records the scope and transfer terms.
Can another brand use the same custom formula?
A full custom formula is treated according to the client ownership and confidentiality terms in the project agreement. This is different from a private-label stock formula, which may be selected by more than one brand.
Can I take an APL custom formula to another manufacturer?
Formula ownership and manufacturing transfer requirements are related but not identical. If portability is important to your business, confirm the formula documents, process information, testing records and any third-party limitations required for an external manufacturer before the project begins.
Do I own the formula if I only change the fragrance or colour of a stock product?
Not automatically. A small adjustment to an existing base is generally a semi-custom project. The written proposal should identify which elements are pre-existing and what rights apply to the modified product.
Is a confidentiality agreement enough?
No. A confidentiality agreement controls disclosure, but it does not by itself assign ownership. The development agreement should cover both confidentiality and IP ownership.
This article provides general commercial information and is not legal advice. Obtain independent legal advice on IP, confidentiality and contract terms for your business.
Start your custom-formulation enquiry | Book a call with APL